Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control

Diabetes, Obesity and Metabolism

Volumn 10, Issue 4, 2008, Pages 329-335

  Aberle, I ^a   Zimprich, D ^a   Bach Kliegel, B ^b   Fischer, C ^c   Gorny, M ^d   Kliegel, A ^e   Langer, K ^d   Kliegel, Matthias ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b KLINIK HIRSLANDEN   (Switzerland)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Darmstadt Hospital   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CSII; Follow up; Long term changes; Mixed models; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RESEARCH; METABOLIC REGULATION; ONSET AGE; OUTCOME ASSESSMENT; PREDICTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 40749133331     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2007.00707.x     Document Type: Article

References (16)

1. Kaufmann FR, Halvorson M, Miller D, Mackenzie M, Fisher LK, Pitukecheewanont P. Insulin pump therapy in type 1 paediatric patients: now and into the year 2000. Diabetes Metab Res Rev 1999; 15: 338-352.
2. Pickup JC, Mattock MB, Kerry S. Glycaemic control with continuous subcutaneous insulin injection therapy in tape 1 diabetes: Meta-analysis of randomised controlled trials. BMJ 2002; 324: 705-710.
3. Weissberg-Benchell J, Antisdel-Lomaglio F, Seshadri R. Insulin pump therapy: A meta-analysis. Diabetes Care 2003; 26: 1079-1087.
4. Hirsch IB. Intensive treatment of type 1 diabetes. In: Skyler JS ed. Prevention and Treatment of Diabetes and its Complications. Philadelphia: Saunders, 1998; 599-610.
5. Rogosa DR, Willett JB. Understanding correlates of change by modeling individual differences in growth. Psychometrika 1985; 50: 203-228.
6. Rizvi AA, Petry R, Arnold MB, Chakraborty M. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes. Endocr Pract 2001; 7: 364-369.
7. Bruttomesso D, Pianta A, Crazzolara D et al. Continuous subcutaneous insulin infusion (CSII) in the Vento region: Efficacy, acceptability and quality of life. Diabet Med 2002; 19: 628-634.
8. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25: 593-598.
9. Brown H, Prescott R. (eds). Applied Mixed Models in Medicine. New York: John Wiley & Sons, 1999.
10. Rubin DB. Inference and missing data. Biometrika 1976; 63: 581-592.
11. Molenberghs G, Verbeke G. A review on linear mixed models for longitudinal data, possibly subject to dropout. Stat Model 2001; 1: 235-268.
12. Hogan JW, Roy J, Korkontzelou C. Biostatistics tutorial: Handling dropout in longitudinal studies. Stat Med 2004; 23: 1455-1497.
13. 1c with low risk of hypoglycemia. J Pediatr Endocrinol 2003; 16: 393-399.
14. Service FJ, O'Brien PC. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia 2001; 44: 1215-1220.
15. Low KG, Massa L, Lehman D, Olshan JS. Insulin pump use in young adolescents with type 1 diabetes: A descriptive study. Pediatr Diabetes 2005; 6: 22-31.
16. Chase HP, Saib SZ, MacKenzie T, Hansen MM, Garg SK. Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes. Diabet Med 2003; 19: 317-321.